Table 3 Associated factors with DNA PCR positivity at 6–8 weeks of age
Variable | DNA-PCR result | p value | Crude OR (95 % CI) | Adjusted OR (95 % CI) | |
|---|---|---|---|---|---|
Positive (%) | Negative (%) | ||||
Sex | 0.992 | ||||
Male | 14 (4.3) | 309 (95.7) | 0.992 | 1.00 (0.46–2.17) | |
Female | 13 (4.3) | 288 (95.7) | Ref | ||
Place of birth | 0.016 | ||||
Health facility | 19 (3.6) | 506 (96.4) | Ref | Ref | |
Home | 6 (10.9) | 49 (89.1) | 3.26 (1.24–8.53) | 3.10 (0.53–18.24) | |
Type of feeding | 0.104 | ||||
Exclusive BF | 16 (3.2) | 478 (96.8) | Ref | ||
Exclusive RF | 6 (6.5) | 85 (93.5) | 2.11 (0.80–5.54) | ||
Mixed feeding | 3 (6.9) | 28 (93.1) | 0.66 (0.16–2.81) | ||
Infant PMTCT | 0.000a | – | |||
Sdb NVP or none | 13 (11.2) | 103 (88.8) | |||
Sd NVP + AZT | 11 (3.9) | 268 (96.1) | |||
Sd NVP ≥6 weeks | 0 (0) | 191 (100) | |||
Mother CD4 during pregnancy | 0.033 | ||||
<100/mm3 | 3 (17.6) | 14 (82.4) | 5.68 (1.15–28.05) | 4.50 (0.71–28.56) | |
100–500/mm3 | 3 (1.3) | 236 (98.7) | 0.34 (0.08–1.53) | 0.26 (0.05–1.33) | |
>500/mm3 | 4 (3.6) | 106 (96.4) | Ref | Ref | |
Mother WHO stage | 0.344 | ||||
WHO stage 1 | 7 (3.3) | 204 (96.7) | Ref | ||
WHO stage 2 | 2 (2.1) | 91 (97.9) | 0.64 (0.13–3.14) | ||
WHO stage 3/4 | 6 (6) | 93 (94) | 1.88 (0.62–5.75) | ||
Mother any PMTCT | 0.000 | ||||
No | 13 (12.7) | 89 (87.3) | 6.10 (2.45–15.17) | 3.80 (0.68–21.09) | |
Yes | 8 (2.3) | 334 (97.7) | Ref | Ref | |
Type of PMTCT (mother) | 0.402 | ||||
AZT only | 2 (4) | 48 (96) | 2.01 (0.39–10.24) | ||
HAART | 6 (2) | 289 (98) | Ref | ||
Antenatal care follow up | 0.000 | ||||
No | 11 (12.8) | 75 (87.2) | 5.54 (2.27–13.52) | 4.05 (0.25–65.75) | |
Yes | 10 (2.6) | 378 (97.4) | Ref | Ref | |
Mother care and treatment | 0.003 | ||||
Enrolled in care and Rxc | 14 (3.3) | 406 (96.7) | Ref | – | |
Not enrolled | 7 (13) | 47 (87) | 4.32 (1.66–11.24) | ||